April 11, 2024 Sophia Vida
Breaking News

Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay

–     Bio-Rad expects to make equity investment in support of deal –     Agreement provides for global exclusivity in transplant monitoring commercialization –     Bio-Rad granted subsequent investment option upon FDA clearance IRVINE, CA, April 11, 2024 – Oncocyte Corporation (NASDAQ: OCX), a precision diagnostics company, today announced a partnership agreement with Bio-Rad Laboratories (NYSE: BIO), a … Continue reading “Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay”